Hassan Y. Ebrahim

999 total citations
41 papers, 789 citations indexed

About

Hassan Y. Ebrahim is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Hassan Y. Ebrahim has authored 41 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Cancer Research. Recurrent topics in Hassan Y. Ebrahim's work include Natural product bioactivities and synthesis (9 papers), Microbial Natural Products and Biosynthesis (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Hassan Y. Ebrahim is often cited by papers focused on Natural product bioactivities and synthesis (9 papers), Microbial Natural Products and Biosynthesis (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Hassan Y. Ebrahim collaborates with scholars based in United States, Egypt and Saudi Arabia. Hassan Y. Ebrahim's co-authors include Khalid A. El Sayed, Mohamed M. Mohyeldin, Heba E. Elsayed, Abu Bakar Siddique, Mohamed R. Akl, Eman G. Haggag, Nehad M. Ayoub, Fatma A. Moharram, Mohamed A. Akl and Ahmed E. Abdel Moneim and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Hassan Y. Ebrahim

40 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hassan Y. Ebrahim United States 18 325 202 163 126 110 41 789
Mohamed M. Mohyeldin United States 19 327 1.0× 227 1.1× 162 1.0× 183 1.5× 163 1.5× 35 958
Kuan‐Han Lee Taiwan 19 292 0.9× 211 1.0× 232 1.4× 68 0.5× 89 0.8× 36 817
Alice A. Ramos Portugal 19 336 1.0× 90 0.4× 173 1.1× 143 1.1× 191 1.7× 38 1.0k
Luca Frattaruolo Italy 18 524 1.6× 129 0.6× 174 1.1× 108 0.9× 126 1.1× 35 1.0k
Kwang-Hee Son South Korea 15 485 1.5× 155 0.8× 95 0.6× 140 1.1× 134 1.2× 20 978
Nadine Kretschmer Austria 18 511 1.6× 202 1.0× 106 0.7× 137 1.1× 215 2.0× 51 978
Ahmed R. Hamed Egypt 19 507 1.6× 230 1.1× 166 1.0× 85 0.7× 271 2.5× 71 1.2k
Verónica Ruiz-Torres Spain 10 213 0.7× 114 0.6× 104 0.6× 126 1.0× 69 0.6× 12 583
Shen‐Chieh Chou Taiwan 14 362 1.1× 267 1.3× 143 0.9× 80 0.6× 130 1.2× 22 888
Ahmed H. El‐Desoky Egypt 17 319 1.0× 128 0.6× 201 1.2× 45 0.4× 131 1.2× 47 678

Countries citing papers authored by Hassan Y. Ebrahim

Since Specialization
Citations

This map shows the geographic impact of Hassan Y. Ebrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Y. Ebrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Y. Ebrahim more than expected).

Fields of papers citing papers by Hassan Y. Ebrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Y. Ebrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Y. Ebrahim. The network helps show where Hassan Y. Ebrahim may publish in the future.

Co-authorship network of co-authors of Hassan Y. Ebrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan Y. Ebrahim. A scholar is included among the top collaborators of Hassan Y. Ebrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan Y. Ebrahim. Hassan Y. Ebrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Siddique, Abu Bakar, et al.. (2023). Pseurotin A Validation as a Metastatic Castration-Resistant Prostate Cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation. Marine Drugs. 21(4). 215–215. 5 indexed citations
4.
Ebrahim, Hassan Y., et al.. (2023). Bioactive metabolites identified from Aspergillus terreus derived from soil. AMB Express. 13(1). 107–107. 3 indexed citations
5.
Abdel‐Razek, Ahmed S., Ahmed A. Hamed, Hassan Y. Ebrahim, et al.. (2023). Antimicrobial, antiproliferative activities and molecular docking of metabolites from Alternaria alternata. AMB Express. 13(1). 68–68. 16 indexed citations
6.
Ebrahim, Hassan Y., et al.. (2022). Melaleuca rugulosa (Link) Craven Tannins: Appraisal of anti-inflammatory, radical scavenging activities, and molecular modeling studies. Journal of Ethnopharmacology. 298. 115596–115596. 12 indexed citations
7.
Siddique, Abu Bakar, et al.. (2022). Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2. Cancers. 14(14). 3542–3542. 16 indexed citations
8.
9.
Siddique, Abu Bakar, Hassan Y. Ebrahim, Mohamed R. Akl, et al.. (2019). (−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo. Nutrients. 11(2). 412–412. 26 indexed citations
10.
Halawa, Ahmed H., Areej A. Eskandrani, Walid E. Elgammal, et al.. (2019). Rational Design and Synthesis of Diverse Pyrimidine Molecules Bearing Sulfonamide Moiety as Novel ERK Inhibitors. International Journal of Molecular Sciences. 20(22). 5592–5592. 18 indexed citations
11.
Siddique, Abu Bakar, Hassan Y. Ebrahim, Mohamed M. Mohyeldin, et al.. (2019). Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLoS ONE. 14(4). e0214798–e0214798. 41 indexed citations
12.
Elsayed, Heba E., et al.. (2017). Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies. Bioorganic & Medicinal Chemistry. 25(24). 6297–6312. 22 indexed citations
13.
Elsayed, Heba E., Hassan Y. Ebrahim, Mohamed M. Mohyeldin, et al.. (2017). Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies. Nutrition and Cancer. 69(8). 1256–1271. 53 indexed citations
14.
Ayoub, Nehad M., Abu Bakar Siddique, Hassan Y. Ebrahim, Mohamed M. Mohyeldin, & Khalid A. El Sayed. (2017). The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment. European Journal of Pharmacology. 810. 100–111. 59 indexed citations
15.
Ebrahim, Hassan Y., Mohamed M. Mohyeldin, Abu Bakar Siddique, et al.. (2016). Abstract 345: Olive oil-based oleocanthal and bioisosteres as c-Met inhibitors for the control of triple negative breast cancer. Cancer Research. 76(14_Supplement). 345–345. 1 indexed citations
16.
Mohyeldin, Mohamed M., Mohamed R. Akl, Hassan Y. Ebrahim, et al.. (2016). The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor. Oncotarget. 7(22). 32247–32273. 17 indexed citations
17.
Akl, Mohamed A., Nehad M. Ayoub, Hassan Y. Ebrahim, et al.. (2015). Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling. Marine Drugs. 13(1). 288–311. 32 indexed citations
18.
Mohyeldin, Mohamed M., Hassan Y. Ebrahim, Heba E. Elsayed, et al.. (2015). The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion. Bioorganic & Medicinal Chemistry. 24(2). 113–122. 47 indexed citations
19.
Behery, Fathy A., Saeed Alqahtani, Hassan Y. Ebrahim, et al.. (2015). PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. 96. 185–195. 26 indexed citations
20.
Ebrahim, Hassan Y., et al.. (2015). Inflammatory metastatic breast cancer with gallbladder metastasis: an incidental finding. The Journal of Community and Supportive Oncology. 13(7). 256–259. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed M. Mohyeldin Breakdown of academic impact, for papers by Kuan‐Han Lee Breakdown of academic impact, for papers by Alice A. Ramos Breakdown of academic impact, for papers by Luca Frattaruolo Breakdown of academic impact, for papers by Kwang-Hee Son Breakdown of academic impact, for papers by Nadine Kretschmer Breakdown of academic impact, for papers by Ahmed R. Hamed Breakdown of academic impact, for papers by Verónica Ruiz-Torres Breakdown of academic impact, for papers by Shen‐Chieh Chou Breakdown of academic impact, for papers by Ahmed H. El‐Desoky
Rankless by CCL
2026